As a consequence, cells and tumours which are GSNOR-deficient are extremely sensitive to SDH inhibition, namely to α-tocopheryl succinate, a molecular targeting SDH, which induced RIP1/PARP1-mediated necroptosis and inhibited the growth of the tumour (171). Here, PARP1 is linked to neoplasm.